Search Results For :: women
-
mHealth Solutions Market by Apps (Women Health, Diabetes, Mental Health), Connected Devices (Glucose & Blood Pressure Monitor, Peak Flow Meter), Services (Remote Monitoring, Consultation), End User (Providers, Patients, Payers) & Region - Global Forecasts to 2028
The global mHealth solutions market in terms of revenue was estimated to be worth $119.5 billion in 2023 and is poised to reach $395.0 billion by 2028, growing at a CAGR of 27.0% from 2023 to 2028.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Feed & Pet Food, Pharma, Functional Food, and Personal Care), End Users (Adults, Pregnant Women, and Children), IU Strength and Region - Global Forecast to 2027
According to MarketsandMarkets, the global vitamin D market is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Zhejiang Garden Biochemical High-Tech Co.Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Women's Healthcare Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) & Region - Global Forecast to 2024
The global women's healthcare market growth is primed to transition from $9.6 billion in 2019 to $17.8 billion by 2024, showcasing a strong CAGR of 13.2%. Key drivers of this growth include increasing chronic health conditions among women, government initiatives for population control, and rising demand for contraceptives.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Dietary Supplements Market, By Type (Botanicals, Vitamins, Minerals, Amino acids, Enzymes, Others), By Category ( Infant Dietary Supplements, Children Dietary Supplements, Adult Dietary Supplements, Pregnant women Dietary Supplements, Old-Aged Dietary Supplements), By Dosage Format (Capsules, Tablets, Powder, Liquids, Soft Gels, Gel Caps)
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Dietary Supplements Market, By Type (Botanicals, Vitamins, Minerals, Amino acids, Enzymes, Others), By Category (Infant Dietary Supplements, Children Dietary Supplements, Adult Dietary Supplements, Pregnant women Dietary Supplements, Old-Aged Dietary Supplements), By Dosage Format (Capsules, Tablets, Powder, Liquids, Soft Gels, Gel Caps)
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
mHealth Solutions Market by Apps (Women Health, Diabetes, Mental Health), Connected Devices (Glucose & Blood Pressure Monitor, Peak Flow Meter), Services (Remote Monitoring, Consultation), End User (Providers, Patients, Payers) & Region - Global Forecasts to 2028
The global mHealth solutions market in terms of revenue was estimated to be worth $119.5 billion in 2023 and is poised to reach $395.0 billion by 2028, growing at a CAGR of 27.0% from 2023 to 2028.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Feed & Pet Food, Pharma, Functional Food, and Personal Care), End Users (Adults, Pregnant Women, and Children), IU Strength and Region - Global Forecast to 2027
According to MarketsandMarkets, the global vitamin D market is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Zhejiang Garden Biochemical High-Tech Co.Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Women's Healthcare Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) & Region - Global Forecast to 2024
The global women's healthcare market growth is primed to transition from $9.6 billion in 2019 to $17.8 billion by 2024, showcasing a strong CAGR of 13.2%. Key drivers of this growth include increasing chronic health conditions among women, government initiatives for population control, and rising demand for contraceptives.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
POP Treatment and Management / Pelvic Organ Prolapse Market by Product (Synthetic Mesh, Sutures, Pessaries, Robotic Systems), Treatment (Surgical, PFMT), Application (Cystocele, Uterine Prolapse), End User (Hospitals, ASCs), Region - Global Forecast to 2030
The global POP Treatment and Management / Pelvic Organ Prolapse market, valued at US$0.72 billion in 2024, stood at US$0.77 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$1.06 billion by the end of the period. The POP Treatment and Management / Pelvic Organ Prolapse market is primarily driven by the rising prevalence of pelvic floor disorders, particularly among aging women, and increased awareness of available treatment options.
- Published: October 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 32
